First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas ...
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for pancreatic cancer, one of the deadliest cancers with limited therapeutic options.
Alpha DaRT ® in pancreatic adenocarcinoma - - Favorable safety profile observed, with only 8 device-associated adverse events in 7 of 26 subjects (27%), nearly all resolving within two weeks in some ...
Using targeted radiation during surgery - referred to as intraoperative radiation - to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins ...
Please provide your email address to receive an email when new articles are posted on . Early research showed nasoduodenal tube delivery of amifostine may help protect the duodenum during radiation ...
Using targeted radiation during surgery - referred to as intraoperative radiation - to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins ...
Add Yahoo as a preferred source to see more of our stories on Google. A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...
Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, today announced that an abstract entitled “Combined Safety and ...
Alpha Tau Medical Ltd ( (DRTS)) has issued an announcement. On April 23, 2026, Alpha Tau Medical announced that it has successfully treated the first European pancreatic cancer patient with its Alpha ...
Pancreatic cancer is a very challenging disease. It’s tough to catch early, spreads rapidly, and doesn’t respond easily to treatment. This year, pancreatic cancer is expected to be the 12th most ...
A new blood test that uses artificial intelligence (AI) may offer a faster, more accurate way to determine whether pancreatic cancer treatment is working. Known as ARTEMIS-DELFI, the test detects DNA ...